Bruce Jackson
Stock Analyst at Benchmark
(0.95)
# 3,506
Out of 4,818 analysts
123
Total ratings
26.05%
Success rate
-24.94%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLTE Belite Bio | Reiterates: Buy | $80 | $58.80 | +36.05% | 9 | Mar 26, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $5.5 → $4.5 | $0.40 | +1,025.00% | 5 | Mar 24, 2025 | |
| HUMA Humacyte | Reiterates: Buy | n/a | $1.47 | - | 14 | Feb 27, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $9.94 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $44.13 | +47.29% | 7 | Jan 13, 2025 | |
| CLNN Clene | Maintains: Buy | $90 → $84 | $2.83 | +2,868.20% | 7 | Nov 22, 2024 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.49 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $3 | $0.63 | +373.04% | 8 | Nov 22, 2024 | |
| MLSS Milestone Scientific | Reiterates: Speculative Buy | $1.25 | $0.94 | +33.62% | 2 | Nov 20, 2024 | |
| BFRI Biofrontera | Reiterates: Buy | $7 | $0.80 | +775.00% | 7 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $0.82 | +264.30% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.50 | +100.00% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.84 | +3,471.43% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $2 | $0.46 | +337.35% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.85 | +1,904.72% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.12 | +2,052.47% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $25 | $2.92 | +757.63% | 6 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $0.46 | +117.39% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $3.01 | +66.11% | 5 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.95 | +426.32% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.95 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.40 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $3.44 | +23,155.81% | 1 | Aug 8, 2022 |
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $58.80
Upside: +36.05%
Harvard Bioscience
Mar 24, 2025
Maintains: Speculative Buy
Price Target: $5.5 → $4.5
Current: $0.40
Upside: +1,025.00%
Humacyte
Feb 27, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.47
Upside: -
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.94
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $44.13
Upside: +47.29%
Clene
Nov 22, 2024
Maintains: Buy
Price Target: $90 → $84
Current: $2.83
Upside: +2,868.20%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.49
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.63
Upside: +373.04%
Milestone Scientific
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.94
Upside: +33.62%
Biofrontera
Nov 15, 2024
Reiterates: Buy
Price Target: $7
Current: $0.80
Upside: +775.00%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.82
Upside: +264.30%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.50
Upside: +100.00%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.84
Upside: +3,471.43%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $2
Current: $0.46
Upside: +337.35%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.85
Upside: +1,904.72%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.12
Upside: +2,052.47%
Jun 3, 2024
Reiterates: Speculative Buy
Price Target: $25
Current: $2.92
Upside: +757.63%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $0.46
Upside: +117.39%
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $3.01
Upside: +66.11%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.95
Upside: +426.32%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.95
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $17.40
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $3.44
Upside: +23,155.81%